SKP2 and breast carcinoma: Further, immunoblot analysis was carried out to evaluate the expression of p27, a pro-apoptotic cyclin D kinase inhibitor, which positively correlates with FOXP3 activity, and SKP2, a breast cancer oncogene known to be suppressed by FOXP3 transcriptional activity [21].